iconpractice Launches Version 2.0 of Cloud-Based Chiropractic Practice Management Platform
Melbourne, Australia--(Newsfile Corp. - July 20, 2025) - iconpractice, the leading cloud-based practice management software designed specifically for chiropractors, osteopaths, and myotherapists, today announced the launch of version 2.0 of its comprehensive platform. The major update represents a complete overhaul of the user interface, delivering a modernized experience while expanding the already robust feature set that has served practices since 2009.
Transforming Healthcare Practice Management
Version 2.0 introduces a completely redesigned interface that prioritizes user experience without compromising the powerful functionality that has made iconpractice the preferred choice for multi-location healthcare practices. The update addresses the evolving needs of modern healthcare professionals who require sophisticated tools that are both intuitive and comprehensive.
'We've grown iconpractice by listening to our users, and version 2.0 is the culmination of years of feedback from practitioners who need their software to work as efficiently as they do,' said Dr. Matthew Holmes, founder and practicing chiropractor who leads iconpractice's development team. 'This isn't just a visual refresh – it's a fundamental reimagining of how practice management software should look and work in 2025.'
Comprehensive Solution for Modern Healthcare Practices
iconpractice v2.0 continues to offer an all-in-one platform that eliminates the need for multiple systems. The updated software includes patient management, clinical notes, billing, performance tracking, and advanced analytics – all accessible from any device with an internet connection.
Key features that set iconpractice apart include:
Revenue Optimization: Built-in tools to prevent revenue leakage through automated reminders, recall tracking, and strategic online booking controls that help practices maintain full schedules.
Patient Retention: Automated follow-up systems and analytics that identify at-risk patients before they drop off, helping practices maintain stronger patient relationships.
Multi-Practice Management: Seamless operation across multiple locations with shared patient data and financial reporting within a single platform instance.
Integration Capabilities: Enhanced connectivity with popular business tools including Mailchimp, Zapier, Tyro payment processing, Xero, and PostureScreen.
Addressing Real-World Healthcare Challenges
The software addresses critical pain points facing healthcare practices today, including appointment gaps, patient retention challenges, and administrative burden. With healthcare professionals needing to focus on patient care rather than paperwork, iconpractice v2.0 streamlines operations while providing the analytical insights needed to grow a successful practice. This makes it perfect chiropractic software for cash practices.
About iconpractice
First launched in 2009 by Dr. Matthew Holmes, iconpractice is a Melbourne-based cloud practice management software specifically for chiropractors, osteopaths, and myotherapists. The platform serves hundreds of practices across Australia, New Zealand, and the USA, ranging from single-practitioner clinics to multi-location enterprises with dozens of staff members.
For more information about iconpractice v2.0, visit www.iconpractice.com or contact:
Media Contact: iconpractice Melbourne, Australia Email: [email protected] Web: www.iconpractice.com
All trademarks are the property of their respective owners.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259421
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
AI and Automation Integration Elevates Laboratory Informatics Demand
The North America laboratory informatics market, valued at USD 1.62 billion in 2024, is set to grow at a CAGR of 4.30% to USD 2.48 billion by 2034. Growth is fueled by cloud-based LIMS, AI, and automation. Pharma and biotech sectors leverage informatics for efficiency, boosting the market with strategic partnerships. North American Laboratory Informatics Market Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "North America Laboratory Informatics Market Report and Forecast 2025-2034" has been added to offering. The North America laboratory informatics market was valued at USD 1.62 billion in 2024, driven by accelerating demand for cloud-based platforms. It is projected to grow at a CAGR of 4.30% from 2025 to 2034, reaching USD 2.48 billion by 2034. Informatics solutions, including LIMS, ELN, SDMS, and CDS, enhance data accuracy, compliance, and workflow automation in industries like pharmaceuticals and biotechnology. Innovations in cloud computing, AI, and automation are transforming laboratory data management by improving decision-making, regulatory compliance, and productivity. Market Growth Drivers and Trends Adoption of unified digital platforms is propelling market growth. The integration of LIMS and ELN functionalities enhances data security and collaboration. For example, eLabNext rebranded its key products into a centralised Digital Lab Platform in October 2024, aligning with market shifts toward streamlined management. The preference for advanced ELN systems is positively impacting market size. TeselaGen Biotechnology launched an enhanced ELN in December 2024, improving productivity and data management in biotech and pharmaceutical research. Global collaborations are strengthening market value. LabWare engaged with biopharma entities in Ireland in June 2024, facilitating knowledge exchange and technological advancements in LIMS adoption. Integration of AI and Automation The demand for AI-driven automation is elevating market demand. Funding initiatives support development in automated chemical laboratories, accelerating innovation and efficiency. By reducing manual errors, AI integrations boost LIMS and ELN system adoption, driving long-term market growth. Emerging Trends Cloud-Based LIMS: With significant IT sector contributions to GDP, cloud solutions are becoming essential for efficiency and compliance. Partnerships such as Revvity Signals Software with Scitara drive innovations in cloud-based platforms for R&D. AI and Automation: Initiatives like Scialog and LabVantage Solutions' integration of mixed reality demonstrate a shift towards AI-driven laboratory processes, enhancing efficiency and research competitiveness. Strategic Partnerships: Collaborations, such as those by LabVantage, are fuelling regulatory compliance and workflow automation, offering growth opportunities in laboratory informatics. Market Segmentation and Key Players: The market is segmented by product, delivery mode, component, end user, and region, with LIMS leading due to its pivotal role in sample management and workflow automation. Cloud solutions are preferred for scalability, while software advancements drive component value. Pharmaceutical companies hold the largest share, driven by stringent regulatory demands and R&D investments. Their adoption of informatics solutions enhances drug development and compliance. Major companies include Serum Institute of India, CSL Limited, Bharat Biotech, and CanSino Biologics, further shaping market dynamics with innovative solutions and global strategies. Region Analysis The United States dominates the market with strong R&D investments and digitalisation, while Canada shows growth due to government initiatives and cloud platform adoption. Both countries advance laboratory informatics with investments in data management and AI solutions. Conclusion The North America laboratory informatics market continues to grow, driven by technological advancements and strategic initiatives. The emphasis on AI, automation, and cloud solutions fosters efficiency and competition in the biotech, pharmaceutical, and research sectors. Key Attributes: Report Attribute Details No. of Pages 300 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $1.62 Billion Forecasted Market Value (USD) by 2034 $2.48 Billion Compound Annual Growth Rate 4.3% Regions Covered North America For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Laboratory Informatics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
$515M Bet on Musk, AI, and Space: Glade Brook Goes All-In While Others Retreat
Glade Brook Capital Partners just pulled in $515 million for its fourth fund and it's placing its bets on the edge of what's next: AI, space, defense, and fintech. The firm, which already holds stakes in SpaceX, Stripe, and Elon Musk's Neuralink, plans to double down on late-stage tech startups navigating some of the most volatile capital markets in recent memory. Founder Paul Hudson didn't sugarcoat the conditions, calling it the most challenging fundraising environment he's seen in his career even as the fund ended up oversubscribed. Despite the headwinds, Glade Brook is leaning into momentum. It's already backing Musk's xAI and Artisan AI, signaling a clear tilt toward artificial intelligence. That comes on top of a portfolio that includes ramping fintech player Ramp and previously backed giants like Uber (NYSE:UBER) and Airbnb (NASDAQ:ABNB). And in a move that tracks closely with broader market appetite, the firm is betting that innovation in complex, capital-intensive sectors like AI and defense could offer asymmetric upside if timed right. Tesla (NASDAQ:TSLA) remains part of the broader Musk-aligned orbit Glade Brook is exposed to, adding even more edge to its late-stage tech focus. Their 2021 fund a $430 million vehicle reportedly ranks in the top 5% of its vintage, according to private Cambridge Associates data. While past performance doesn't guarantee future returns, it does suggest Glade Brook knows how to play late-stage cycles. In a market where many VCs are stuck in wait-and-see mode, Glade Brook appears to be playing offense betting that when the next wave breaks, it'll be the firms already in position that ride it the farthest. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
IRS offers $2.895 million settlement with Maple Lawn over COVID-19 funding
COLDWATER, MI — County owned Maple Lawn Medical Care Facility received written confirmation Tuesday, July 22 of a settlement offer of $2.895 million from the IRS of an appeal of COVID-19 grants owed from the Employee Retention Credit program. Director Jayne Sabaitis told her board July 16 if confirmed, she would accept the offer after appealing denial of the original $3.6 million request filed three years ago during the pandemic. The money will help Maple Lawn make up for its current $1.3 million operating deficit caused by reduction in Medicaid funding for the current federal fiscal year. Prior story Maple Lawn to appeal IRS denial of $3.6 million in COVID-19 relief funds Sabaitis told her board she would consult with accountants Plante-Moran. 'We'll be discussing how that's going to affect our cost report. We want to make sure that we keep our expenses so that our Medicaid rate stays the same to make sure the use of the funds would not hurt next year's Medicaid funding," she said. Sabaitis told the board there are some capital projects which were delayed. 'We're not going to take this money and blow it. We want to hold cash as much as we can' with questions about future funding, she said. Related story With a current $1.2 million loss, Maple Lawn faces concerns with federal Medicaid cuts Sabaitis said five other Michigan nursing homes hired Washington legal counsel to sue the IRS over ERC denial. Maple Lawn was a late applicant for ERC funding only learning near the end of the pandemic the non-profit nursing facilities were eligible. The program was created for eligible businesses and tax-exempt organizations that had employees and saw increased costs or losses affected during the COVID-19 pandemic. Subscribe Support local to the Coldwater Reporter Maple Lawn is licensed for 114 beds but fluctuates by staffing. The nursing care and rehabilitation regularly reports over 90% occupancy. Contact Don Reid: dReid@ This article originally appeared on Coldwater Daily Reporter: Maple Lawn to receive $2.895 million ERC program settlement from IRS Solve the daily Crossword
